Artículos adicionales, disponibles públicamente, que reportan resultados de estudios clínicos de fase 3 y de efectividad con la vacuna CoronaVac:
Efficacy and Safety of a COVID-19 Inactivated Vaccine in Healthcare Professionals in Brazil: The PROFISCOV Study.
[Eficacia y seguridad de una vacuna inactivada contra COVID-19 en profesionales de la salud en Brasil: el estudio PROFISCOV.
Autores: Palacios, Ricardo and Batista, Ana Paula and Albuquerque, Camila Santos Nascimento and Patiño, Elizabeth González and Santos, Joane do Prado and Tilli Reis Pessoa Conde, Mônica and Piorelli, Roberta de Oliveira and Pereira Júnior, Luiz Carlos and Raboni, Sonia Mara and Ramos, Fabiano and Sierra Romero, Gustavo Adolfo and Leal, Fábio Eudes and Camargo, Luis Fernando Aranha and Aoki, Francisco Hideo and Coelho, Eduardo Barbosa and Oliveira, Danise Senna and Fontes, Cor Jesus Fernandes and Pileggi, Gecilmara Cristina Salviato and Oliveira, Ana Lúcia Lyrio de and Siqueira, André Machado de and Oliveira, Danielle Bruna Leal de and Botosso, Viviane Fongaro and Zeng, Gang and Xin, Qianqian and Teixeira, Mauro Martins and Nogueira, Maurício Lacerda and Kallas, Esper Georges.
https://ssrn.com/abstract=3822780
Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey.
[Eficacia y seguridad de una vacuna de virus completo SARS-CoV-2 inactivado (CoronaVac): resultados interinos de un estudio clínico fase 3, doble-ciego, aleatorizado, controlado por placebo en Turquía.].
Autores: Prof Mine Durusu Tanriover, MD, Prof Hamdi Levent Doğanay, MD, Prof Murat Akova, MD, Prof Hatice Rahmet Güner, MD, Prof Alpay Azap, MD, Prof Sıla Akhan, MD, Prof Şükran Köse, MD, Prof Fatma Şebnem Erdinç, MD, Prof Emin Halis Akalın, MD, Prof Ömer Fehmi Tabak, MD, Prof Hüsnü Pullukçu, MD, Özgür Batum, MD, Prof Serap Şimşek Yavuz, MD, Prof Özge Turhan, MD, Mustafa Taner Yıldırmak, MD, Prof İftihar Köksal, MD.
Prof Yeşim Taşova, MD, Prof Volkan Korten, MD, Prof Gürdal Yılmaz, MD, Prof Mustafa Kemal Çelen, MD, Prof Sedat Altın, MD, Prof İlhami Çelik, MD, Prof Yaşar Bayındır, MD, Prof İlkay Karaoğlan, MD, Prof Aydın Yılmaz, MD, Prof Aykut Özkul, DVM, Hazal Gür, MSc, Prof Serhat Unal, MD, and the CoronaVac Study Group.
Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile.
[Efectividad de una vacuna inactivada contra SARS-CoV-2 en Chile].
Autores:Alejandro Jara, Ph.D., Eduardo A. Undurraga, Ph.D., Cecilia González, M.D., Fabio Paredes, M.Sc., Tomás Fontecilla, M.Sc., Gonzalo Jara, B.S.E., Alejandra Pizarro, M.D., Johanna Acevedo, M.S., Katherinne Leo, B.S.E., Francisco Leon, M.B.A., Carlos Sans, B.S.E., Paulina Leighton, B.S.E., Pamela Suárez, B.S.E., Heriberto García-Escorza, M.S., and Rafael Araos, M.D.
Prof Yeşim Taşova, MD, Prof Volkan Korten, MD, Prof Gürdal Yılmaz, MD, Prof Mustafa Kemal Çelen, MD, Prof Sedat Altın, MD, Prof İlhami Çelik, MD, Prof Yaşar Bayındır, MD, Prof İlkay Karaoğlan, MD, Prof Aydın Yılmaz, MD, Prof Aykut Özkul, DVM, Hazal Gür, MSc, Prof Serhat Unal, MD, and the CoronaVac Study Group
https://www.nejm.orgEffectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile
[Efectividad de una vacuna inactivada contra SARS-CoV-2 en Chile]
Autores: Alejandro Jara, Ph.D., Eduardo A. Undurraga, Ph.D., Cecilia González, M.D., Fabio Paredes, M.Sc., Tomás Fontecilla, M.Sc., Gonzalo Jara, B.S.E., Alejandra Pizarro, M.D., Johanna Acevedo, M.S., Katherinne Leo, B.S.E., Francisco Leon, M.B.A., Carlos Sans, B.S.E., Paulina Leighton, B.S.E., Pamela Suárez, B.S.E., Heriberto García-Escorza, M.S., and Rafael Araos, M.D.
https://www.nejm.org/doi/full/10.1056/NEJMoa2107715